Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug

被引:59
|
作者
Carlyle, Wenda C. [1 ]
McClain, James B. [1 ]
Tzafriri, Abraham R. [2 ,3 ]
Bailey, Lynn [2 ]
Zani, Brett G. [2 ]
Markham, Peter M. [2 ]
Stanley, James R. L. [2 ]
Edelman, Elazer R. [3 ]
机构
[1] Micell Technol Inc, Durham, NC 27713 USA
[2] CBSET Inc, Concord Biomed Sci & Emerging Technol, Lexington, MA 02421 USA
[3] MIT, Cambridge, MA 02139 USA
关键词
Stent; PLGA; Crystalline; Sirolimus; Modeling; Pharmacokinetic; ELUTING STENT; RELEASE; DEPOSITION; SIROLIMUS; ARTERIAL;
D O I
10.1016/j.jconrel.2012.07.004
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Current drug eluting stent (DES) technology is not optimized with regard to the pharmacokinetics of drug delivery. A novel, absorbable-coating sirolimus-eluting stent (AC-SES) was evaluated for its capacity to deliver drug more evenly within the intimal area rather than concentrating drug around the stent struts and for its ability to match coating erosion with drug release. The coating consisted of absorbable poly-lactide-co-glycolic acid (PLGA) and crystalline sirolimus deposited by a dry-powder electrostatic process. The AC-SES demonstrated enhanced drug stability under simulated use conditions and consistent drug delivery balanced with coating erosion in a porcine coronary implant model. The initial drug burst was eliminated and drug release was sustained after implantation. The coating was absorbed within 90 days. Following implantation into porcine coronary arteries the AC-SES coating is distributed in the surrounding intimal tissue over the course of several weeks. Computational modeling of drug delivery characteristics demonstrates how distributed coating optimizes the load of drug immediately around each stent strut and extends drug delivery between stent struts. The result was a highly efficient arterial uptake of drug with superior performance to a clinical bare metal stent (BMS). Neointimal thickness (0.17+/-0.07 mm vs. 0.28+/-0.11 mm) and area percent stenosis (22+/-9% vs. 35+/-12%) were significantly reduced (p<0.05) by the AC-SES compared to the BMS 30 days after stent implantation in an overlap configuration in porcine coronary arteries. Inflammation was significantly reduced in the AC-SES compared to the BMS at both 30 and 90 days after implantation. Biocompatible, rapidly absorbable stent coatings enable the matching of drug release with coating erosion and provide for the controlled migration of coating material into tissue to reduce vicissitudes in drug tissue levels, optimizing efficacy and reducing potential toxicity. (C) 2012 Elsevier B. V. All rights reserved.
引用
收藏
页码:561 / 567
页数:7
相关论文
共 50 条
  • [1] Titratable drug delivery from drug filled stents
    Tzafriri, Abraham R.
    Markham, Peter
    Goshgarian, Justin
    Schulz-Jander, Daniel
    Tunev, Stefan
    Melder, Robert J.
    Stone, Gregg W.
    Edelman, Elazer R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B224 - B225
  • [2] Polymer-free Drug-Coated Coronary Stents
    Cavalcante, Rafael
    Sotomi, Yohei
    Onuma, Yoshinobu
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (09): : 892 - 892
  • [3] Will nanoporous stents replace polymer-based stents for drug and gene delivery?
    Wholey, MH
    JOURNAL OF ENDOVASCULAR THERAPY, 2005, 12 : 48 - 48
  • [4] Drug-coated stents
    Poerner, TC
    Haase, KK
    Wiesinger, B
    Wiskirchen, J
    Duda, SH
    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2002, 11 (04) : 185 - 192
  • [5] Drug Coated Stents are not on a par
    Klein, Friederike
    DIABETOLOGIE UND STOFFWECHSEL, 2016, 11 (01) : 26 - 26
  • [6] Fabrication of coated polymer microneedles for transdermal drug delivery
    Chen, Yang
    Chen, Bo Zhi
    Wang, Qi Lei
    Jin, Xuan
    Guo, Xin Dong
    JOURNAL OF CONTROLLED RELEASE, 2017, 265 : 14 - 21
  • [7] Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents
    Chen, Weiluan
    Habraken, Tom C. J.
    Hennink, Wim E.
    Kok, Robbert J.
    BIOCONJUGATE CHEMISTRY, 2015, 26 (07) : 1277 - 1288
  • [8] Polymer-free Drug-Coated Coronary Stents Reply
    Urban, Philip
    Morice, Marie-Claude
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (09): : 893 - 893
  • [9] Coating defects in polymer-coated drug-eluting stents
    Bedair, Tarek M.
    Cho, Youngjin
    Park, Bang Ju
    Joung, Yoon Ki
    Han, Dong Keun
    BIOMATERIALS AND BIOMECHANICS IN BIOENGINEERING, 2014, 1 (03): : 131 - 150
  • [10] BIOCOMPATIBILITY EVALUATION OF DRUG RELEASING ABSORBABLE VASCULAR STENTS
    Liu, Si W.
    Weng, Ching S.
    Wang, Wei J.
    Liu, Yuan H.
    Wu, Vin C.
    Wang, Ming C.
    BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS, 2018, 30 (05):